导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.05% | 2579/4776 |
| 近一周 | -1.56% | 4034/5443 |
| 近一月 | -1.45% | 2023/5405 |
| 近一季 | -1.17% | 2562/5197 |
| 近半年 | -2.10% | 2466/4908 |
| 近一年 | 3.50% | 2520/4337 |
| 近两年 | 27.50% | 2436/2951 |
| 近三年 | 21.69% | 1483/2241 |
| 成立以来 | 63.76% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.60% 1881/4961 |
7.23% 2734/5312 |
- - |
- - |
| 2025 | 11.06% 2766/4813 |
-1.25% 2618/3635 |
3.93% 908/4076 |
5.80% 3563/4524 |
2.28% 1015/4813 |
| 2024 | 13.87% 1100/3463 |
3.85% 507/2808 |
1.88% 433/3014 |
10.34% 2630/3129 |
-2.46% 2090/3463 |
| 2023 | -7.38% 915/2656 |
2.28% 1384/2280 |
-3.83% 920/2385 |
-1.09% 480/2515 |
-4.80% 1177/2655 |
| 2022 | -10.70% 214/2207 |
-11.25% 491/1919 |
6.39% 713/2016 |
-8.28% 186/2113 |
3.12% 768/2208 |
| 2021 | 3.59% 606/1822 |
1.19% 261/1255 |
4.45% 885/1330 |
-4.01% 675/1466 |
2.11% 699/1822 |
| 2020 | 31.92% 493/1250 |
-8.32% 601/1028 |
13.77% 594/1067 |
15.45% 213/1164 |
9.55% 633/1184 |
| 2019 | 33.74% 425/1092 |
20.96% 602/754 |
3.26% 52/804 |
1.28% 418/850 |
5.72% 684/918 |
| 2018 | - - |
- - |
- - |
- - |
-10.40% 194/691 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 平安MSCI中国A股ETF VS. 长安沪深300非周期A(740101) |